BioCity Nottingham

BioCity Nottingham

Biocity buildings
Formation	September 2003
Legal status	Science park
Purpose	Bioscience innovation
Location	Pennyfoot Street, Nottingham, NG1 1GF
Region served	UK
Membership	70 companies
Chief Executive	Dr Glenn Crocker
Main organ	BioCity Board (Chairman – Dr Louis Nisbet)
Affiliations	Nottingham Trent University, University of Nottingham,
Website	BioCity

BioCity Nottingham is a bioscience science park in central Nottingham in the United Kingdom. It is the UK's largest bioscience innovation and incubation centre.

In 2002, laboratories and office space were donated to Nottingham Trent University by BASF. Biocity was founded in September 2003 by the University of Nottingham, Nottingham Trent University (NTU) and the East Midlands Development Agency (which is based close to BioCity).

Biocity's premises were developed from the building donated by BASF. Phase 1 was completed in March 2004, providing 36,000 sq ft (3,300 m²) of space, then Phase 2 in March 2006 provided 24,000 sq ft (2,200 m²). When Phase 3 of the development was completed in October 2008, with 45,000 sq ft (4,200 m²), funding from emda also finished.

Nottingham has long been an important centre for bioscience research, principally through work done at the University of Nottingham, Nottingham Trent University and by Boots, Britain's largest retail pharmacy company, which is based in Dunkirk/Beeston. Although Boots no longer engages in drug discovery, Ibuprofen (iso-butyl-propanoic-phenolic acid) was created by Boots scientists in Nottingham. In March 2005 Nottingham was named as a Science City; the other 5 Science Cities were Birmingham,Bristol, York, Newcastle and Manchester.

It is situated in former BASF buildings, which previously were used by Boots as research laboratories.

The site on Pennyfoot Street, between the A60 and A612, is for bioscience SMEs. The University of Nottingham has the largest collaboration with companies at BioCity, with a few having links with NTU.

...
Wikipedia